UK Medical Cannabis Drugs Market Analysis

UK Medical Cannabis Drugs Market Analysis


$ 3999

UK medical cannabis drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Globally, there are more people with chronic illnesses, which will probably result in an increase in patients, and people are becoming more interested in living healthy lives. Additionally, it's projected that a rise in product approvals and increased R&D for cannabis-related medical devices will fuel market growth. The major key players in this market are Tilray, Bedrocan International, Canopy Growth Corporation, Aurora Cannabis Inc., Vivo Cannabis Inc., Maricann Inc., Medical Marijuana Inc., Organigram Holdings Inc., The Scotts Company LLC, Curaleaf Holdings, Inc.

ID: IN10GBPH327 CATEGORY: Pharmaceuticals GEOGRAPHY: UK AUTHOR: Aneri Parekh

Buy Now

UK Medical Cannabis Drugs Market Analysis Summary

UK Medical Cannabis Drugs Market is valued at around $321.3 Mn in 2022 and is projected to reach $1456.9 Mn by 2030, exhibiting a CAGR of 20.8% during the forecast period 2023-2030.

Cannabis is now used to treat a variety of conditions and symptoms, such as those brought on by cancer, diabetes, chronic pain, epilepsy, depression, arthritis, glaucoma, migraines, multiple sclerosis, Alzheimer’s disease, AIDS, Amyotrophic Lateral Sclerosis (ALS), Post Traumatic Stress Disorder (PTSD), Parkinson's disease, and Tourette's syndrome. This is one of the key ideas in the medicinal cannabis sector. Cannabis has been approved for medical usage in a number of nations with varied degrees of regulatory restrictions because to its therapeutic effects. When compared to other therapeutic treatments, cannabis is risk-free and has just modest negative effects. It is also used in conjunction with other therapies, either to boost their effectiveness or minimise undesirable side effects. The market for medical cannabis gains from this. Globally, there are more people with chronic illnesses, which will probably result in an increase in patients, and people are becoming more interested in living healthy lives. Additionally, it's projected that a rise in product approvals and increased R&D for cannabis-related medical devices will fuel market growth. The major key players in this market are Tilray, Bedrocan International, Canopy Growth Corporation, Aurora Cannabis Inc., Vivo Cannabis Inc., Maricann Inc., Medical Marijuana Inc., Organigram Holdings Inc., The Scotts Company LLC, Curaleaf Holdings, Inc.

Market Dynamics

Market Growth Drivers

Globally, there are more people with chronic diseases, which is likely to increase the number of patients, and there is a growing preference for leading healthy lives. Additionally, it is anticipated that an increase in the number of product approvals and rising R&D efforts for medical cannabis devices will fuel market expansion. Also increased use of cannabis in medicines is another factor that acts as a driver for medica cannabis drugs market.

Market Restraints

Market growth is expected to be constrained by factors such as the high cost of medical cannabis operations and devices, pharmaceutical costs, safety concerns, unfavourable laser treatment outcomes, and a lack of awareness regarding the therapeutic use of laser devices. And it's anticipated that a dearth of qualified specialists and strict rules will hinder business expansion.

Competitive Landscape

Key Players

  • Tilray
  • Bedrocan International
  • Canopy Growth Corporation
  • Aurora Cannabis Inc.
  • Vivo Cannabis Inc.
  • Maricann Inc.
  • Medical Marijuana Inc.
  • Organigram Holdings Inc.
  • The Scotts Company LLC
  • Curaleaf Holdings, Inc.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

UK Medical Cannabis Drugs Market Segmentation

By Derivatives

  • Cannabidiol (CBD)
  • Tetrahydrocannabinol (THC)

By Administration

  • Oral Solutions and Capsules
  • Smoking
  • Vaporizers
  • Topicals
  • Others

By Applications

  • Cancer
  • Arthritis
  • Migraine
  • Epilepsy
  • Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 27 February 2024
Updated by: Bhanu Pratap Singh

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up